![Benjamin Oakes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Benjamin Oakes
Founder at
SCRIBE THERAPEUTICS INC.
Net worth: 10 M $ as of 2026-07-30
Profile
Benjamin L.
Oakes is President, Chief Executive Officer, and Director at Scribe Therapeutics, Inc. Dr. Oakes is the founder of Scribe Therapeutics, Inc., founded in 2017.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-07-26 | 506,602 ( 2.69% ) | 10 M $ | 2026-07-30 |
Benjamin Oakes active positions
| Companies | Position | Start |
|---|---|---|
| SCRIBE THERAPEUTICS INC. | Founder | 2017-05-31 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
10
1st degree connections
1
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 1 |
|---|---|
Scribe Therapeutics, Inc.
 Scribe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops CRISPR-based genetic medicines to extend healthy lifespan through disease prevention and durable therapeutic interventions | Health Technology |
- Stock Market
- Insiders
- Benjamin Oakes
